Behavioural Activation
Cross-source consensus on Behavioural Activation from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Preparation
Comparisons
Highlighted claims
- Behavioural activation conceptualises depression as maintained by insufficient environmental reinforcement and negatively reinforced avoidance. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Behavioural activation identifies and reduces avoidance while increasing reinforcing activity. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Behavioural activation is used as the active comparator because it is an evidence-based psychotherapy for depression. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- In the early BA phase, baseline activities, avoidance behaviour, life goals, and values are assessed to create an individual disease model and goals. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Continuation group therapy in the BA arm mainly focuses on self-activation and troubleshooting. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial